Genenta Science (GNTA)

• Market cap: $19.4M
• 1 day: 37.35%
• 5 days: 32.53%
• 1 month: 11.22%
• 3 months: -17.18%
• 6 months: -59.18%
• Year to date: -41.81%
• 1 year: -81.22%
• 5 years: -92.54%
• 10 years: -92.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 9